Arcus Biosciences, Inc. (RCUS) Insider Trading
Over the last 3 months, RCUS insiders made 0 open-market buys and 6 sales, a net sale of -$1.1M (SEC Form 4). Over the last 6 months, 184 institutions increased and 98 reduced their position (13F).
Insider Activity
Sentiment
0/100
Buys (3m)
0
Sells (3m)
6
Net (3m)
-$1.1M
Insider trades by month Buys Sells
Oct
Nov
Dec
Jan
May
Jun
Context3-month price +34.2%Institutions accumulating (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jun 24, 2026 | Jaen Juan C.officer: President | Sell | 9,236 | $27.03 |
| Jun 24, 2026 | Jaen Juan C.officer: President | Sell | 6,431 | $29.66 |
| Jun 24, 2026 | Jaen Juan C.officer: President | Sell | 1,697 | $28.06 |
| Jun 24, 2026 | Jaen Juan C.officer: President | Sell | 14,067 | $27.69 |
| Jun 12, 2026 | Tang Carolyn C.officer: General Counsel | Option | 34,090 | $2.57 |
| Jun 12, 2026 | Ribas Antonidirector | Grant | 16,900 | $23.30 |
| Jun 12, 2026 | FALBERG KATHRYN Edirector | Grant | 5,700 | — |
| Jun 12, 2026 | Lacey David L.director | Grant | 16,900 | $23.30 |
| Jun 12, 2026 | Lambert Nicoledirector | Grant | 16,900 | $23.30 |
| Jun 12, 2026 | Machado Patrickdirector | Grant | 5,700 | — |
| Jun 12, 2026 | Lacey David L.director | Grant | 5,700 | — |
| Jun 12, 2026 | KANEKO YASUNORIdirector | Grant | 16,900 | $23.30 |
| Jun 12, 2026 | PERLMAN ANDREW Jdirector | Grant | 5,700 | — |
| Jun 12, 2026 | Ribas Antonidirector | Grant | 5,700 | — |
| Jun 12, 2026 | PERLMAN ANDREW Jdirector | Grant | 16,900 | $23.30 |
| Jun 12, 2026 | Machado Patrickdirector | Grant | 16,900 | $23.30 |
| Jun 12, 2026 | KANEKO YASUNORIdirector | Grant | 5,700 | — |
| Jun 12, 2026 | Lambert Nicoledirector | Grant | 5,700 | — |
| Jun 12, 2026 | FALBERG KATHRYN Edirector | Grant | 16,900 | $23.30 |
| Jun 1, 2026 | Azoy Alexanderofficer: Chief Accounting Officer | Sell | 2,562 | $25.77 |
| May 12, 2026 | Goeltz II Robert C.officer: Chief Financial Officer | Sell | 7,763 | $25.63 |
| Jan 26, 2026 | Jarrett Jenniferofficer: Chief Operating Officer | Grant | 126,000 | $22.13 |
| Jan 26, 2026 | Jaen Juan C.officer: President | Grant | 126,000 | $22.13 |
| Jan 26, 2026 | Jarrett Jenniferofficer: Chief Operating Officer | Grant | 31,000 | — |
| Jan 26, 2026 | Azoy Alexanderofficer: Chief Accounting Officer | Grant | 14,050 | $22.13 |
| Jan 26, 2026 | Jaen Juan C.officer: President | Grant | 31,000 | — |
| Jan 26, 2026 | Markus Richardofficer: Chief Medical Officer | Grant | 24,000 | — |
| Jan 26, 2026 | Azoy Alexanderofficer: Chief Accounting Officer | Grant | 21,050 | — |
| Jan 26, 2026 | Goeltz II Robert C.officer: Chief Financial Officer | Grant | 24,000 | — |
| Jan 26, 2026 | ROSEN TERRY Jdirector, officer: Chief Executive Officer | Grant | 315,000 | $22.13 |
Source: RCUS SEC Form 4 filings, latest Jun 24, 2026. For informational purposes only — not investment advice.
Institutional activity (13F)
How institutions changed their RCUS positions over the last 6 months (SEC Form 13F).
Increased
184
New positions
84
Reduced
98
Sold out
64
Largest moves
| Institution | Action | Shares | Filed |
|---|---|---|---|
| GILEAD SCIENCES, INC. | Unchanged | 31.4M | May 8, 2026 |
| GILEAD SCIENCES, INC. | Unchanged | 31.4M | Feb 12, 2026 |
| BLACKROCK, INC. | Increased | 15.2M | May 13, 2026 |
| BLACKROCK, INC. | Increased | 15.0M | Feb 12, 2026 |
| VANGUARD GROUP INC | Increased | 8.0M | Jan 29, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 7.7M | May 15, 2026 |
| WOODLINE PARTNERS LP | Increased | 7.6M | May 15, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | Increased | 6.1M | May 15, 2026 |
| STATE STREET CORP | Increased | 5.4M | May 15, 2026 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | Increased | 5.2M | Feb 17, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | Increased | 5.2M | Feb 17, 2026 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | Reduced | 5.0M | May 15, 2026 |
| STATE STREET CORP | Increased | 4.6M | Feb 13, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | New Position | 4.3M | May 8, 2026 |
| WOODLINE PARTNERS LP | Increased | 3.8M | Feb 17, 2026 |
Source: SEC Form 13F filings. For informational purposes only — not investment advice.